Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

MSLI 1.46 -0.02 (-1.35%)
price chart
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
TORONTO, ONTARIO, Sep 08, 2014 (Marketwired via COMTEX) -- Merus Labs International Inc. ("Merus" or the "Company") (MSL) MSLI, +2.76% is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in ...
Merus Labs Acquire Sintrom from Novartis  Pharmaceutical Processing
Related articles »  
Merus Labs International Inc. Announces Completion of $7 Million Financing ...
14, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that, further to its news release dated July 4, 2014, the Company has today completed the financing acquisition transaction with Dacha ...
Related articles »  
Merus Labs International Inc. Completes $20 Million Bought Deal Financing
Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters") co-led by Cormark ...
Related articles »  
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
Closing Bell Reports: Merus Labs International Inc. (MSLI), The St. Joe ...
Merus Labs International Inc. (MSLI) of the Healthcare sector lost -4.49%, a change from open of -1.9700% ($-0.07 per share) at the close of the normal trading day Friday, November 7th, 2014 with a volume of 16005 shares.
EmergingGrowth.com looks at Merus Labs International Inc. After Better than ...
May 28, 2013 (ACCESSWIRE via COMTEX) -- Merus Labs International Inc. MSLI, +2.76% (MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.
Related articles »  
Merus Labs International Inc. Announces Conversion of $10 Million Convertible ...
In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest.
Related articles »  
Merus Labs International Inc. Announces $22.1 Million Bought Deal Financing
TORONTO, June 11, 2014 /CNW/ - Merus Labs International Inc. ("the Company" or "Merus") [TSX: MSL] [NASDAQ: MSLI] is pleased to announce that it has entered into an agreement with a syndicate of investment dealers co-led by Canaccord Genuity Corp ...
Merus Labs rockets 20% on $27 mln bought deal offering  Proactive Investors USA & Canada
Low share price no obstacle as Merus Labs, Madalena Energy raise equity  Financial Post
Related articles »  
Merus Labs International Inc. Announces Closing of $10 Million Preferred Share ...
TORONTO, ONTARIO--(Marketwired - July 11, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has completed its previously announced private placement issuance of ...
Related articles »  
Merus Labs International Inc. Announces Board Appointment
TORONTO, ONTARIO--(Marketwired - May 27, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that it has appointed Theresa Firestone to its board of directors.
Related articles »